December 16, 2025

LivaNova PLC (LIVN) Investor Outlook: Exploring a Promising 9.58% Potential Upside

LivaNova PLC (NASDAQ: LIVN), a key player in the medical devices industry, is drawing investor attention with its noteworthy potential upside of 9.58%. As a company headquartered in London, UK,..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a 63.55% Potential Upside in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO), a prominent player in the healthcare sector, is capturing investor attention with a notable potential upside of 63.55%, as highlighted by its average target price...

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Evaluating a 13.16% Potential Upside Amidst Market Challenges

DENTSPLY SIRONA Inc. (NASDAQ: XRAY) stands as a significant player in the healthcare sector, specifically within the medical instruments and supplies industry. With a rich history dating back to 1877,..

Alvotech (ALVO) Stock Analysis: Unpacking a Potential 310% Upside in the Biosimilar Market

Alvotech (NASDAQ: ALVO) is emerging as a dynamic player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Based in Luxembourg, the company is making strides..

Aptamer Group signs first licensing deal with Twist Bioscience

Aptamer Group has entered into its first licensing agreement with Twist Bioscience, granting a non-exclusive licence for the use of an Optimer® binder in hot-start PCR and next-generation sequencing products...

PPHE Hotel Group refinances Park Plaza Victoria London

PPHE Hotel Group has agreed a new £88 million refinancing facility for Park Plaza Victoria London, replacing an existing loan due to mature in early 2026...

Greggs Plc appoints Richard Smothers as Non-Executive Director

Greggs plc has announced the appointment of Richard Smothers as an independent Non-Executive Director, effective from 1 February 2026...

Hollywood Bowl Group reports FY2025 results with revenue growth

Hollywood Bowl Group has published its audited results for the year ended 30 September 2025, reporting revenue growth of 8.8% to £250.7m and a fourth consecutive year of record revenue..

Centrica Plc agrees sale of Spirit Energy assets to Serica

Centrica has announced the sale of Spirit Energy’s remaining interests in the Cygnus gas field and other producing assets in the Southern North Sea to Serica Energy...

AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer

AstraZeneca and Daiichi Sankyo have received US FDA approval for Enhertu in combination with pertuzumab as a 1st-line treatment for adults with unresectable or metastatic HER2-positive breast cancer...

GSK Plc secures UK approval for Exdensur in asthma and nasal polyps

GSK has announced that Exdensur (depemokimab) has received marketing authorisation from the UK MHRA for use in certain asthma and chronic rhinosinusitis with nasal polyps patients...

Anglo American and Teck secure Canadian approval for merger

Anglo American and Teck Resources have received approval from the Government of Canada under the Investment Canada Act for their proposed merger of equals...

Manx Financial Group issues new shares following RSU vesting

Manx Financial has announced the exercise of Restricted Stock Units over 2,072,500 new ordinary shares at nil cost. The share issues relate to vested awards granted in November 2023 and..

Time Finance reports H1 2025/26 trading update with profit growth

The AIM listed finance provider recorded higher new business origination, an expanded lending book, and increased profit before tax, alongside lower arrears and write-offs, supporting confidence that full year performance..

Bodycote PLC (BOY.L) Stock Analysis: Unveiling a 12.35% Potential Upside Amidst Industrial Challenges

Bodycote PLC (BOY.L), a prominent player in the specialty industrial machinery industry, is capturing investor attention with a projected upside of 12.35%. As a leader in heat treatment and thermal..

FirstGroup PLC (FGP.L) Stock Analysis: Exploring a 33% Potential Upside With Robust Dividend Yield

Investors seeking opportunities in the UK transport sector should take a closer look at FirstGroup PLC (FGP.L), a key player in the public transport industry focusing on bus and rail..

Hilton Food Group PLC (HFG.L): Investor Outlook with a Compelling 53.92% Potential Upside

Hilton Food Group PLC (HFG.L) stands as a notable entity in the Consumer Defensive sector, specifically within the Packaged Foods industry. With its headquarters nestled in Huntingdon, United Kingdom, Hilton..

Goodwin PLC (GDWN.L) Stock Analysis: Examining Growth Potential and Industrial Prowess

Goodwin PLC (LSE: GDWN.L), a stalwart in the Specialty Industrial Machinery sector, has been captivating investors’ attention with its robust growth trajectory. Headquartered in Stoke-On-Trent, United Kingdom, this century-old company..

Bakkavor Group PLC (BAKK.L): Evaluating the 3.47% Dividend Yield Amidst Modest Growth Prospects

Bakkavor Group PLC (BAKK.L) operates in the consumer defensive sector, specializing in the packaged foods industry. Known for its fresh prepared foods, Bakkavor serves major markets in the United Kingdom,..

Bankers Investment Trust PLC (BNKR.L) Stock Analysis: Navigating Steady Waters with a Strong Market Cap

Bankers Investment Trust PLC (BNKR.L) has long been a staple for investors seeking diversified exposure to global equity markets. With a robust market capitalization of $1.3 billion, this investment trust..

Search

Funds

December 16, 2025

Aptamer Group signs first licensing deal with Twist Bioscience

Aptamer Group has entered into its first licensing agreement with Twist Bioscience, granting a non-exclusive licence for the use of an Optimer® binder in hot-start PCR and next-generation sequencing products...

PPHE Hotel Group refinances Park Plaza Victoria London

PPHE Hotel Group has agreed a new £88 million refinancing facility for Park Plaza Victoria London, replacing an existing loan due to mature in early 2026...

Greggs Plc appoints Richard Smothers as Non-Executive Director

Greggs plc has announced the appointment of Richard Smothers as an independent Non-Executive Director, effective from 1 February 2026...

Hollywood Bowl Group reports FY2025 results with revenue growth

Hollywood Bowl Group has published its audited results for the year ended 30 September 2025, reporting revenue growth of 8.8% to £250.7m and a fourth consecutive year of record revenue and adjusted EBITDA...

Centrica Plc agrees sale of Spirit Energy assets to Serica

Centrica has announced the sale of Spirit Energy’s remaining interests in the Cygnus gas field and other producing assets in the Southern North Sea to Serica Energy...

AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer

AstraZeneca and Daiichi Sankyo have received US FDA approval for Enhertu in combination with pertuzumab as a 1st-line treatment for adults with unresectable or metastatic HER2-positive breast cancer...

GSK Plc secures UK approval for Exdensur in asthma and nasal polyps

GSK has announced that Exdensur (depemokimab) has received marketing authorisation from the UK MHRA for use in certain asthma and chronic rhinosinusitis with nasal polyps patients...

Anglo American and Teck secure Canadian approval for merger

Anglo American and Teck Resources have received approval from the Government of Canada under the Investment Canada Act for their proposed merger of equals...

Manx Financial Group issues new shares following RSU vesting

Manx Financial has announced the exercise of Restricted Stock Units over 2,072,500 new ordinary shares at nil cost. The share issues relate to vested awards granted in November 2023 and include allocations to directors and a PDMR, with admission to trading on AIM expected on 23 December 2025...

Time Finance reports H1 2025/26 trading update with profit growth

The AIM listed finance provider recorded higher new business origination, an expanded lending book, and increased profit before tax, alongside lower arrears and write-offs, supporting confidence that full year performance will be in line with market guidance...
Search

Funds

December 16, 2025

FTSE 100

Funds